In the last 12 months, insiders at RenovoRx, Inc. ($RNXT) filed 67 transactions with the SEC: 39 open-market purchases totaling $222,823 and 0 sales totaling $0. Net insider sentiment: net buying.
RenovoRx, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Agah Ramtin (Chief Medical Officer) — 19 transactions totaling $161,107
- Bagai Shaun (Chief Executive Officer) — 15 transactions totaling $41,486
- Marton Laurence (Director) — 9 transactions totaling $13,290
- Kocak Ron (VP Controller and PAO) — 3 transactions totaling $10,011
- Kocak Ron (VP, Controller and PAO) — 3 transactions totaling $0
View all SEC Filings for RenovoRx, Inc. (RNXT).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 25, 2026 | VOLL MARK | Chief Financial Officer | A | Common Stock | 12380 | $0.00 | 134,580.0000 | 36,649,916 | 10.13% | 0.03% |
| March 20, 2026 | Bagai Shaun | Chief Executive Officer | P | Common Stock | 24300 | $0.00 | 364,340.0000 | 36,649,916 | 7.15% | 0.07% |
| March 20, 2026 | Marton Laurence | Director | P | Common Stock | 9720 | $0.00 | 9,720.0000 | 36,649,916 | 9999.99% | 0.03% |
| March 20, 2026 | Marton Laurence | Director | P | Warrants | 4860 | $0.00 | 4,860.0000 | 36,649,916 | 9999.99% | 0.01% |
| March 20, 2026 | VOLL MARK | Chief Financial Officer | P | Warrants | 48600 | $0.00 | 48,600.0000 | 36,649,916 | 9999.99% | 0.13% |
| March 20, 2026 | VOLL MARK | Chief Financial Officer | P | Common Stock | 97200 | $0.00 | 97,200.0000 | 36,649,916 | 9999.99% | 0.27% |
| March 20, 2026 | Bagai Shaun | Chief Executive Officer | P | Warrants | 12150 | $0.00 | 12,150.0000 | 36,649,916 | 9999.99% | 0.03% |
| Jan. 21, 2026 | Agah Ramtin | Chief Medical Officer | P | Common Stock | 10000 | $1.00 | 798,460.0000 | 36,649,916 | 1.27% | 0.03% |
| Dec. 31, 2025 | Agah Ramtin | Chief Medical Officer | P | Common Stock | 9795 | $0.86 | 788,460.0000 | 36,649,916 | 1.26% | 0.03% |
| Dec. 30, 2025 | Agah Ramtin | Chief Medical Officer | P | Common Stock | 205 | $0.83 | 778,665.0000 | 36,649,916 | 0.03% | 0.00% |
| Dec. 18, 2025 | Bagai Shaun | Chief Executive Officer | P | Common Stock | 5000 | $0.90 | 340,040.0000 | 36,649,916 | 1.49% | 0.01% |
| Dec. 17, 2025 | Bagai Shaun | Chief Executive Officer | P | Common Stock | 5000 | $0.85 | 335,040.0000 | 36,649,916 | 1.51% | 0.01% |
| Dec. 16, 2025 | Agah Ramtin | Chief Medical Officer | P | Common Stock | 12000 | $0.85 | 778,460.0000 | 36,649,916 | 1.57% | 0.03% |
| Dec. 5, 2025 | Agah Ramtin | Chief Medical Officer | P | Common Stock | 10000 | $0.96 | 766,460.0000 | 36,649,916 | 1.32% | 0.03% |
| Nov. 21, 2025 | Agah Ramtin | Chief Medical Officer | P | Common Stock | 10000 | $0.80 | 744,460.0000 | 36,649,916 | 1.36% | 0.03% |
| Nov. 24, 2025 | Agah Ramtin | Chief Medical Officer | P | Common Stock | 12000 | $0.80 | 756,460.0000 | 36,649,916 | 1.61% | 0.03% |
| Oct. 1, 2025 | Marton Laurence | Director | A | Stock Options (right to buy) | 47640 | $0.00 | 47,640.0000 | 36,546,752 | 9999.99% | 0.13% |
| Oct. 1, 2025 | RYAN UNA S | Director | A | Stock Options (right to buy) | 47640 | $0.00 | 47,640.0000 | 36,546,752 | 9999.99% | 0.13% |
| Oct. 1, 2025 | Macfarlane K. Angela | Director | A | Stock Options (right to buy) | 47640 | $0.00 | 47,640.0000 | 36,546,752 | 9999.99% | 0.13% |
| Oct. 1, 2025 | Spiegel Robert J. | Director | A | Stock Options (right to buy) | 47640 | $0.00 | 47,640.0000 | 36,546,752 | 9999.99% | 0.13% |
| Aug. 25, 2025 | Bagai Shaun | Chief Executive Officer | P | Common Stock | 5000 | $0.91 | 330,040.0000 | 36,546,752 | 1.54% | 0.01% |
| Aug. 22, 2025 | Bagai Shaun | Chief Executive Officer | P | Common Stock | 5000 | $0.95 | 325,040.0000 | 36,546,752 | 1.56% | 0.01% |
| July 1, 2025 | Agah Ramtin | Chief Medical Officer | A | Stock Option | 63636 | $0.00 | 63,636.0000 | 36,546,752 | 9999.99% | 0.17% |
| July 1, 2025 | Kocak Ron | VP, Controller and PAO | A | Stock Option | 41600 | $0.00 | 41,600.0000 | 36,546,752 | 9999.99% | 0.11% |
| July 1, 2025 | Gentry Leesa | Chief Clinical Officer | A | Stock Option | 6619 | $0.00 | 6,619.0000 | 36,546,752 | 9999.99% | 0.02% |
| July 1, 2025 | Bagai Shaun | Chief Executive Officer | A | Stock Option | 102498 | $0.00 | 102,498.0000 | 36,546,752 | 9999.99% | 0.28% |
| June 5, 2025 | Agah Ramtin | Chief Medical Officer | P | Common Stock | 21000 | $1.40 | 734,460.0000 | 36,546,752 | 2.94% | 0.06% |
| April 22, 2025 | Agah Ramtin | Chief Medical Officer | G | Common Stock | 400000 | $0.00 | 713,460.0000 | 36,546,752 | 35.92% | 1.09% |
| May 2, 2025 | Marton Laurence | Director | M | Stock Option (right to buy) | 20480 | $0.00 | 0.0000 | 36,546,752 | 100.00% | 0.06% |
| May 2, 2025 | Marton Laurence | Director | M | Common Stock | 20480 | $0.15 | 66,164.0000 | 36,546,752 | 44.83% | 0.06% |
| April 15, 2025 | Agah Ramtin | Chief Medical Officer | P | Common Stock | 15000 | $0.90 | 1,113,460.0000 | 36,546,752 | 1.37% | 0.04% |
| April 14, 2025 | Bagai Shaun | Chief Executive Officer | A | Stock Option | 409992 | $0.00 | 409,992.0000 | 36,546,752 | 9999.99% | 1.12% |
| April 14, 2025 | Gentry Leesa | Chief Clinical Officer | A | Stock Option | 26477 | $0.00 | 26,477.0000 | 36,546,752 | 9999.99% | 0.07% |
| April 14, 2025 | Kocak Ron | VP, Controller and PAO | A | Stock Option | 166400 | $0.00 | 166,400.0000 | 36,546,752 | 9999.99% | 0.46% |
| April 14, 2025 | Agah Ramtin | Chief Medical Officer | A | Stock Option | 254542 | $0.00 | 254,542.0000 | 36,546,752 | 9999.99% | 0.70% |
| April 15, 2025 | Bagai Shaun | Chief Executive Officer | P | Common Stock | 7500 | $0.91 | 320,040.0000 | 36,546,752 | 2.40% | 0.02% |
| April 11, 2025 | Agah Ramtin | Chief Medical Officer | P | Common Stock | 20000 | $0.80 | 1,098,460.0000 | 36,546,752 | 1.85% | 0.05% |
| April 9, 2025 | Agah Ramtin | Chief Medical Officer | P | Common Stock | 30000 | $0.81 | 1,078,460.0000 | 36,546,752 | 2.86% | 0.08% |
| April 8, 2025 | Kocak Ron | VP Controller and PAO | P | Common Stock | 95 | $0.80 | 95.0000 | 36,546,752 | 9999.99% | 0.00% |
| April 9, 2025 | Kocak Ron | VP Controller and PAO | P | Common Stock | 6000 | $0.80 | 6,095.0000 | 36,546,752 | 6315.79% | 0.02% |
| April 10, 2025 | Kocak Ron | VP Controller and PAO | P | Common Stock | 6500 | $0.79 | 12,595.0000 | 36,546,752 | 106.64% | 0.02% |
| April 9, 2025 | Bagai Shaun | Chief Executive Officer | P | Common Stock | 10000 | $0.83 | 312,540.0000 | 36,546,752 | 3.31% | 0.03% |
| April 8, 2025 | Agah Ramtin | Chief Medical Officer | P | Common Stock | 26000 | $0.84 | 1,048,460.0000 | 36,546,752 | 2.54% | 0.07% |
| April 8, 2025 | Marton Laurence | Director | P | Common Stock | 12050 | $0.85 | 45,684.0000 | 36,546,752 | 35.83% | 0.03% |
| April 7, 2025 | Bagai Shaun | Chief Executive Officer | P | Common Stock | 10000 | $0.83 | 302,540.0000 | 36,546,752 | 3.42% | 0.03% |
| Oct. 1, 2024 | Spiegel Robert J. | Director | A | Stock Options (right to buy) | 25099 | $0.00 | 25,099.0000 | 0 | 9999.99% | 0.00% |
| Oct. 1, 2024 | Marton Laurence | Director | A | Stock Options (right to buy) | 25099 | $0.00 | 25,099.0000 | 0 | 9999.99% | 0.00% |
| Oct. 1, 2024 | Macfarlane K. Angela | Director | A | Stock Options (right to buy) | 25099 | $0.00 | 25,099.0000 | 0 | 9999.99% | 0.00% |
| Oct. 1, 2024 | RYAN UNA S | Director | A | Stock Options (right to buy) | 25099 | $0.00 | 25,099.0000 | 0 | 9999.99% | 0.00% |
| March 6, 2024 | Gentry Leesa | Chief Clinical Officer | A | Options | 190000 | $0.00 | 190,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2024 | Kocak Ron | VP, Controller and PAO | A | Options | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 26, 2024 | Bagai Shaun | Chief Executive Officer | P | Common Stock | 40983 | $0.00 | 292,540.0000 | 0 | 16.29% | 0.00% |
| Jan. 26, 2024 | Spiegel Robert J. | Director | P | Warrants | 40983 | $0.00 | 40,983.0000 | 0 | 9999.99% | 0.00% |
| Jan. 26, 2024 | Agah Ramtin | Chief Medical Officer | P | Warrants | 40983 | $0.00 | 40,983.0000 | 0 | 9999.99% | 0.00% |
| Jan. 26, 2024 | Spiegel Robert J. | Director | P | Common Stock | 40983 | $0.00 | 40,983.0000 | 0 | 9999.99% | 0.00% |
| Jan. 26, 2024 | Bagai Shaun | Chief Executive Officer | P | Warrants | 40983 | $0.00 | 40,983.0000 | 0 | 9999.99% | 0.00% |
| Jan. 26, 2024 | Macfarlane K. Angela | Director | P | Warrant Shares | 40983 | $0.00 | 40,983.0000 | 0 | 9999.99% | 0.00% |
| Jan. 26, 2024 | Macfarlane K. Angela | Director | P | Common Stock | 40983 | $0.00 | 40,983.0000 | 0 | 9999.99% | 0.00% |
| Jan. 26, 2024 | Marton Laurence | Director | P | Warrants | 8196 | $0.00 | 8,196.0000 | 0 | 9999.99% | 0.00% |
| Jan. 26, 2024 | Marton Laurence | Director | P | Common Stock | 8196 | $0.00 | 33,634.0000 | 0 | 32.22% | 0.00% |
| Jan. 26, 2024 | Agah Ramtin | Chief Medical Officer | P | Common Stock | 40983 | $0.00 | 47,460.0000 | 0 | 632.75% | 0.00% |
| Jan. 19, 2024 | Bagai Shaun | Chief Executive Officer | A | Stock Option | 66973 | $0.00 | 66,973.0000 | 0 | 9999.99% | 0.00% |
| Jan. 19, 2024 | Agah Ramtin | Chief Medical Officer | A | Stock Option | 125132 | $0.00 | 125,132.0000 | 0 | 9999.99% | 0.00% |
| Jan. 19, 2024 | Agah Ramtin | Chief Medical Officer | A | Stock Option | 28424 | $0.00 | 28,424.0000 | 0 | 9999.99% | 0.00% |
| Jan. 19, 2024 | Nelms Angela | Chief Operating Officer | A | Stock Option | 125132 | $0.00 | 125,132.0000 | 0 | 9999.99% | 0.00% |
| Jan. 19, 2024 | Nelms Angela | Chief Operating Officer | A | Stock Option | 33768 | $0.00 | 33,768.0000 | 0 | 9999.99% | 0.00% |
| Jan. 19, 2024 | Bagai Shaun | Chief Executive Officer | A | Stock Option | 250263 | $0.00 | 250,263.0000 | 0 | 9999.99% | 0.00% |